2018-3-20
PROFESSIONAL COOPERATION AND TECHNIQUES FOR LEPU MEDICAL IN NEURO INTERVENTIONAL MARKETS
Prof. Pedro Lylyk, Neurosurgeon, Director and CEO of ENERI and Clínica La Sagrada Familia in Buenos Aires, Argentina, visited Shanghai Changhai Hospital to anticipate three surgeries cooperated with Prof. Jianmin Liu, the chief director of department of neurosurgery on 16, Mar, 2018...
2017-12-12
MEMOPARTTM PDA OCCLUDER SUCCESSFULLY RESCUED CHILDREN WITH COMPLEX CONGENITAL HEART IN PAKISTAN
On November 10, 2017, Dr. Khurram Akhtar, Dr. Mehboob Sultan and Dr. Adiba Akhtar Khalil of the Pakistani Military Heart Hospital published a case of a complex PDA occlusion with MemopartTM cone shape PDA occluder on the Journal of Cardiology & Current Research.
2017-8-10
NOTICE ON ACCEPTATION OF MEDICAL DEVICE REGISTRATION FOR BIOABSORBABLE DRUG-ELUTING (RAPAMYCIN) STENT SYSTEM
The registration of Lepu Medical’s blockbuster product, NeoVasTM, the bioabsorbable drug-eluting (rapamycin) stent system, has been accepted on August 8th, 2017. It is expected to become the first domestic company to receive the registration...
2017-07-11
LEPU MEDICAL EXPECTED NET PROFIT OF FIRST HALF OF 2017 TO BE 528 MILLION CNY (79 MILLION USD), YEAR-ON-YEAR GROWTH REACHED UP TO 40%
Lepu Medical released earnings pre-annunciation of the first half of 2017, expected a net profit of 491 million to 528 million CNY. Comparing to 377 million CNY for the same period last year, the year-on-year growth rate reached up to 30% - 40%.
2017-03-05
LEPU MEDICAL AND SIEMENS ESTABLISH THE STRATEGIC COOPERATION FOR NEW DEVELOPMENT OF DSA
Lepu Medical and Siemens CV Division (Germany) signed an agreement to build the long-term strategic cooperation on the basis of DSA equipment’s components supply, technology, software, R&D and other related services.
2016-06-05
2016 ASIA PACIFIC DISTRIBUTOR MEETING
The Asia Pacific Distributor Meeting was conducted by Lepu Medical International Sales & Marketing Department in Pattaya, Thailand. It was the first meeting held by Lepu Medical including internal communication and product training.
2016-05-21
NEW RELEASED CLINICAL RESULTS AT EURO PCR OF NEWVASTM, THE BVS OF LEPU MEDICAL
At EuroPCR 2016, Lepu Medical released the latest 6-month and 1-year follow-up results of the First-in-Man Study for NeoVasTM, the bioresorbable sirolimus-eluting coronary scaffold. The result showed the performance of NeoVasTM reached the leading level...
2016-05-03
LEPUCARE, A SUBSIDIARY ESTABLISHED IN INDIA
Lepucare (India) Vascular Solutions Private Limited isa subsidiary of Lepu Medical in India. It was established and incorporated recently. LEPUCARE has successfully got approval by the Government of India, Ministry of Corporate Affairs in the Central...